<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The monocyte receptor for <z:mp ids='MP_0001794'>bacterial</z:mp> <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> CD14 is an important mediator of the <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, a polymorphism in the promotor of the CD14 gene, C (-260) T, was detected as a risk factor for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: We tested the hypotheses that this polymorphism is a risk factor 1. for <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in general and 2. for <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> due to large artery <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> or <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> in particular </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: We performed a case control study including 151 consecutive patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> treated at our university hospital and 149 control subjects </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> control subjects were randomly selected from the general population of the same region in South-West Germany </plain></SENT>
<SENT sid="5" pm="."><plain>Genotype frequencies of the C(-260) T polymorphism in the promotor of the CD14 gene were examined by restriction length analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The TT-genotype was not associated with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in general either in univariate or in multivariate analysis together with classical vascular risk factors (odds ratio in multivariate analysis: 1.11; 95 %CI, 0.63 to 1.95) </plain></SENT>
<SENT sid="7" pm="."><plain>In 70 patients with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> due to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> of large arteries or <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e>, there was a significantly higher prevalence of the TT-genotype than into control subjects (38.6 % vs. 23.5 %; odds ratio in multivariate analysis 2.26; 95 %CI, 1.13 to 4.54) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We demonstrated that the TT-genotype of the CD14 C(-260) T polymorphism in a South-German population is not associated with an increased risk of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in general </plain></SENT>
<SENT sid="9" pm="."><plain>However, we found that the TT-genotype is associated with a risk of atherosclerotic or microangiopathic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>This finding requires confirmation by future studies in larger populations </plain></SENT>
</text></document>